Showing results (351-360 of 374) with videos related to
Sort By:
Pageof 38
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal CancerJashodeep Datta, J Joshua Smith, Walid K Chatila, et al.JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|December 26, 2025
A Developmental Roadmap Toward Abdominal Adhesions Prevention TechnologiesReid R Christensen, Kyla E Wright, James K Ives, et al.Diseases of the Colon and Rectum|January 14, 2025
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-WaitRoni Y Rosen, Aron P Bercz, Dana M Omer, et al.Communications Biology|February 12, 2022
Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistanceSabine Ottilie, Madeline R Luth, Erich Hellemann, et al.Nature Reviews. Clinical Oncology|August 5, 2021
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Ane Appelt, Robert Glynne-Jones, et al.International Journal of Radiation Oncology, Biology, Physics|November 13, 2024
Clinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Intensity-Modulated Radiation TherapyDiana A Roth O'Brien, Vasilis C Hristidis, Zakaria Chakrani, et al.Nature Communications|February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitorsCristina Valero, Mark Lee, Douglas Hoen, et al.Emerging Infectious Diseases|December 11, 2022
Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020-2021Joshua Smith-Sreen, Bridget Miller, Alinune N Kabaghe, et al.Pageof 38